Wallington Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-20,150
| Closed | -$355K | – | 62 |
|
|
2017
Q3 | $355K | Sell |
20,150
-1,455
| -7% | -$25.6K | 0.09% | 53 |
|
|
2017
Q2 | $718K | Sell |
21,605
-1,140
| -5% | -$37.9K | 0.2% | 48 |
|
|
2017
Q1 | $730K | Sell |
22,745
-895
| -4% | -$28.7K | 0.21% | 50 |
|
|
2016
Q4 | $857K | Sell |
23,640
-23,755
| -50% | -$861K | 0.27% | 48 |
|
|
2016
Q3 | $2.18M | Sell |
47,395
-2,510
| -5% | -$116K | 0.72% | 42 |
|
|
2016
Q2 | $2.51M | Sell |
49,905
-190
| -0.4% | -$9.55K | 0.78% | 41 |
|
|
2016
Q1 | $2.68M | Sell |
50,095
-870
| -2% | -$46.6K | 0.88% | 38 |
|
|
2015
Q4 | $3.35M | Sell |
50,965
-120
| -0.2% | -$7.88K | 1.15% | 33 |
|
|
2015
Q3 | $2.88M | Sell |
51,085
-680
| -1% | -$38.4K | 1.04% | 38 |
|
|
2015
Q2 | $3.06M | Sell |
51,765
-1,590
| -3% | -$94K | 0.98% | 41 |
|
|
2015
Q1 | $3.32M | Sell |
53,355
-1,040
| -2% | -$64.8K | 1.04% | 41 |
|
|
2014
Q4 | $3.13M | Sell |
54,395
-730
| -1% | -$42K | 1% | 42 |
|
|
2014
Q3 | $2.96M | Sell |
55,125
-710
| -1% | -$38.2K | 1% | 40 |
|
|
2014
Q2 | $2.93M | Sell |
55,835
-5,265
| -9% | -$276K | 1% | 40 |
|
|
2014
Q1 | $3.23M | Sell |
61,100
-1,800
| -3% | -$95.1K | 1.14% | 40 |
|
|
2013
Q4 | $2.52M | Sell |
62,900
-730
| -1% | -$29.3K | 0.92% | 41 |
|
|
2013
Q3 | $2.4M | Buy |
63,630
+1,630
| +3% | +$61.6K | 0.99% | 39 |
|
|
2013
Q2 | $2.43M | Buy |
+62,000
| New | +$2.43M | 1.03% | 38 |
|